CA ($5.29B) NJ ($3.10B) NC ($2.61B) TX ($1.76B) OH ($1.57B) NY ($1.36B) IL ($1.07B) AL ($1.03B) FL ($759.09M) AZ ($724.70M) VA ($679.19M) MA ($650.91M) WA ($621.53M) PA ($613.16M) PR ($574.01M) TN ($532.19M) WI ($515.28M) MI ($447.07M) KY ($431.86M) WV ($412.13M) LA ($399.22M) GA ($356.92M) MD ($332.45M) RI ($307.56M) OR ($305.21M) UT ($275.34M) KS ($272.36M) MN ($268.74M) CO ($243.37M) OK ($162.03M) NM ($155.60M) NV ($135.43M) IN ($129.10M) HI ($117.95M) SC ($111.07M) MO ($94.51M) CT ($69.12M) IA ($66.07M) ME ($36.98M) DE ($34.87M) MS ($30.31M) ND ($27.54M) SD ($24.21M) VT ($15.62M) AR ($14.57M) ID ($12.94M) DC ($12.61M) MT ($11.32M) NE ($10.69M) NH ($1.97M) AK ($1.82M) PUERTO RICO ($1.52M) VI ($1.27M) WY ($271K) P.R. ($2K)
| Code | Description | Total Paid |
|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | $2.89B |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | $1.62B |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | $985.69M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | $907.10M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | $904.11M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | $868.33M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | $861.61M |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | $586.85M |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | $553.18M |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | $522.57M |
| # | Provider | Location | Claims | Total Paid |
|---|---|---|---|---|
| 1 | LABORATORY CORPORATION OF AMERICA HOLDINGS | BURLINGTON, NC | 103,910,314 | $1.44B |
| 2 | LABORATORY CORPORATION OF AMERICA HOLDINGS | RARITAN, NJ | 109,455,732 | $717.47M |
| 3 | UNILAB CORPORATION | WEST HILLS, CA | 111,637,602 | $668.50M |
| 4 | NATERA, INC. | SAN CARLOS, CA | 7,257,656 | $641.51M |
| 5 | QUEST DIAGNOSTICS INCORPORATED | CLIFTON, NJ | 57,184,397 | $637.74M |
| 6 | BIOREFERENCE HEALTH, LLC | ELMWOOD PARK, NJ | 60,790,152 | $620.07M |
| 7 | LABORATORY CORPORATION OF AMERICA HOLDINGS | DUBLIN, OH | 53,462,000 | $617.02M |
| 8 | MILLENNIUM HEALTH, LLC | SAN DIEGO, CA | 30,684,871 | $579.29M |
| 9 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | CHARLOTTESVILLE, VA | 7,181,828 | $500.55M |
| 10 | QUEST DIAGNOSTICS LLC IL | WOOD DALE, IL | 29,324,170 | $429.84M |
| 11 | TEXAS DEPARTMENT OF STATE HEALTH | AUSTIN, TX | 2,710,132 | $381.85M |
| 12 | STATE OF ALABAMA DEPARTMENT OF PUBLIC HEALTH | PRATTVILLE, AL | 4,710,077 | $373.63M |
| 13 | SONORA QUEST LABORATORIES LLC | PHOENIX, AZ | 28,495,059 | $298.05M |
| 14 | LABORATORY CORPORATION OF AMERICA HOLDINGS | BIRMINGHAM, AL | 29,662,567 | $289.12M |
| 15 | LABORATORY CORPORATION OF AMERICA HOLDINGS | RESEARCH TRIANGLE PARK, NC | 4,783,978 | $281.44M |
| 16 | QUEST DIAGNOSTICS CLINICAL LABORATORIES INC | IRVING, TX | 26,910,771 | $276.76M |
| 17 | EXACT SCIENCES LABORATORIES, LLC | MADISON, WI | 983,414 | $276.55M |
| 18 | LABORATORY CORPORATION OF AMERICA | PHOENIX, AZ | 31,036,545 | $265.90M |
| 19 | LABORATORY CORPORATION OF AMERICA HOLDINGS | BURLINGTON, NC | 15,254,290 | $264.26M |
| 20 | DOMINION DIAGNOSTICS, LLC | NORTH KINGSTOWN, RI | 5,526,819 | $249.15M |
| 21 | LABORATORY CORPORATION OF AMERICA HOLDINGS | CHARLESTON, WV | 8,750,297 | $220.04M |
| 22 | PRECISION TOXICOLOGY, LLC | SAN DIEGO, CA | 5,645,867 | $213.77M |
| 23 | LABONE LLC | LENEXA, KS | 15,295,177 | $212.28M |
| 24 | QUEST DIAGNOSTICS CLINICAL LABORATORIES INC | TUCKER, GA | 19,587,798 | $211.13M |
| 25 | QUEST DIAGNOSTICS LLC | MARLBOROUGH, MA | 45,938,450 | $209.74M |
| 26 | PHYSICIANS GROUP LABORATORIES, LLC | HOUMA, LA | 4,619,179 | $208.13M |
| 27 | QUEST DIAGNOSTICS MASSACHUSETTS LLC | MARLBOROUGH, MA | 17,471,892 | $199.86M |
| 28 | NORTHWELL HEALTH LABORATORIES | NEW HYDE PARK, NY | 10,616,684 | $198.24M |
| 29 | QUEST DIAGNOSTICS CLINICAL LABORATORIES INC | MIRAMAR, FL | 24,341,922 | $197.58M |
| 30 | AEGIS SCIENCES CORPORATION | NASHVILLE, TN | 7,411,693 | $193.81M |
| 31 | LABORATORY CORPORATION OF AMERICA | SEATTLE, WA | 17,061,269 | $186.69M |
| 32 | HEALTHTRACKRX INDIANA, INC | DENTON, TX | 6,668,299 | $186.02M |
| 33 | ACCU REFERENCE MEDICAL LAB, LLC | LINDEN, NJ | 12,016,657 | $183.01M |
| 34 | GENETIC DISEASE SCREENING PROGRAM, STATE OF CA | RICHMOND, CA | 925,570 | $182.46M |
| 35 | LABORATORY CORPORATION OF AMERICA | TAMPA, FL | 37,608,686 | $171.13M |
| 36 | LABONE OF OHIO INC | CINCINNATI, OH | 11,892,402 | $167.17M |
| 37 | CLINICAL PATHOLOGY LABORATORIES, INC. | AUSTIN, TX | 17,848,189 | $159.40M |
| 38 | LABORATORY CORPORATION OF AMERICA | SAN DIEGO, CA | 64,360,026 | $147.14M |
| 39 | MYRIAD WOMEN'S HEALTH, INC. | SOUTH SAN FRANCISCO, CA | 1,284,222 | $146.98M |
| 40 | SOUTHERN OHIO MEDICAL CENTER | PORTSMOUTH, OH | 3,493,646 | $145.26M |
| 41 | EUROFINS DIATHERIX LABORATORIES LLC | HUNTSVILLE, AL | 4,714,639 | $145.14M |
| 42 | EMPIRE CITY LABORATORIES, INC | BROOKLYN, NY | 13,619,013 | $142.98M |
| 43 | UNILAB CORPORATION | SACRAMENTO, CA | 29,528,771 | $141.24M |
| 44 | INFINITY DIAGNOSTICS LABORATORY, INC | TETERBORO, NJ | 5,169,150 | $138.00M |
| 45 | INVITAE CORPORATION | SAN FRANCISCO, CA | 996,226 | $136.73M |
| 46 | QUEST DIAGNOSTICS OF PENNSYLVANIA, INC. | PITTSBURGH, PA | 11,245,781 | $132.39M |
| 47 | MYRIAD GENETIC LABORATORIES, INC. | SALT LAKE CITY, UT | 386,281 | $124.78M |
| 48 | WEST VIRGINIA UNIVERSITY HOSPITALS, INC | MORGANTOWN, WV | 2,888,713 | $124.09M |
| 49 | QUEST DIAGNOSTICS INCORPORATED MD | BALTIMORE, MD | 8,337,844 | $121.81M |
| 50 | HOLZER HOSPITAL FOUNDATION | GALLIPOLIS, OH | 1,946,441 | $121.51M |
| 51 | GRAVITY DIAGNOSTICS, LLC | COVINGTON, KY | 3,771,600 | $116.16M |
| 52 | LABORATORY CORPORATION OF AMERICA HOLDINGS | RESEARCH TRIANGLE PARK, NC | 5,070,325 | $115.71M |
| 53 | QUEST DIAGNOSTICS CLINICAL LABORATORIES INC | SEATTLE, WA | 9,197,808 | $109.23M |
| 54 | SHERMAN ABRAMS LABORATORY INC | BROOKLYN, NY | 7,606,468 | $107.89M |
| 55 | WELLNOW URGENT CARE, PC | LIVERPOOL, NY | 2,180,426 | $106.41M |
| 56 | LENCO DIAGNOSTIC LABORATORIES,INC. | BROOKLYN, NY | 9,250,114 | $105.14M |
| 57 | LABORATORY CORPORATION OF AMERICA | HOUSTON, TX | 11,078,864 | $103.81M |
| 58 | SUNRISE MEDICAL LABORATORIES, INC. | HICKSVILLE, NY | 10,153,997 | $101.48M |
| 59 | AMMON ANALYTICAL LABORATORIES LLC | LINDEN, NJ | 1,553,284 | $98.75M |
| 60 | A2CL SERVICES, LLC | WEST ALLIS, WI | 5,951,837 | $98.74M |
| 61 | MAKO MEDICAL LABORATORIES, LLC | RALEIGH, NC | 3,111,690 | $97.92M |
| 62 | GENOMIC HEALTH, INC. | REDWOOD CITY, CA | 49,037 | $96.56M |
| 63 | QUEST DIAGNOSTICS VENTURE LLC | PITTSBURGH, PA | 3,644,771 | $96.03M |
| 64 | GENTECH LABORATORIES LLC | DALLAS, TX | 1,132,422 | $91.80M |
| 65 | BEXAR COUNTY HOSPITAL DISTRICT | SAN ANTONIO, TX | 2,104,292 | $91.62M |
| 66 | ASSUREX HEALTH, INC. | MASON, OH | 2,742,565 | $90.31M |
| 67 | CURATIVE LABS INC. | SAN DIMAS, CA | 2,074,086 | $87.61M |
| 68 | ATLANTIC DIAGNOSTIC LABORATORIES, LLC. | BENSALEM, PA | 1,912,901 | $87.05M |
| 69 | FULGENT THERAPEUTICS, LLC. | EL MONTE, CA | 2,346,002 | $84.90M |
| 70 | BUREAU OF PUBLIC HEALTH LABORATORIES | JACKSONVILLE, FL | 9,055,352 | $81.69M |
| 71 | MEDICAL DIAGNOSTIC LABORATORIES,LLC | HAMILTON, NJ | 4,890,327 | $80.98M |
| 72 | BILLIONTOONE INC | UNION CITY, CA | 715,490 | $78.03M |
| 73 | LABORATORY CORPORATION OF AMERICA | ENGLEWOOD, CO | 6,373,382 | $77.80M |
| 74 | LABORATORY CORPORATION OF AMERICA | DALLAS, TX | 9,486,407 | $77.42M |
| 75 | TOTAL WELLNESS CENTERS, LLC | HOLYOKE, MA | 1,875,235 | $77.17M |
| 76 | SEQUENOM CENTER FOR MOLECULAR MEDICINE LLC | SAN DIEGO, CA | 238,481 | $74.16M |
| 77 | INTERPATH LABORATORY, INC. | PENDLETON, OR | 5,418,620 | $70.05M |
| 78 | DIAGNOSTIC LABORATORY OF OKLAHOMA LLC | OKLAHOMA CITY, OK | 4,083,383 | $69.01M |
| 79 | SALEM HEALTH | SALEM, OR | 1,458,232 | $65.77M |
| 80 | TRICORE REFERENCE LABORATORIES | ALBUQUERQUE, NM | 3,234,572 | $64.46M |
| 81 | LABORATORY SERVICES COOPERATIVE | BREMERTON, WA | 2,104,995 | $64.03M |
| 82 | SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP | N HOLLYWOOD, CA | 6,517,662 | $63.44M |
| 83 | PATHGROUP LABS, LLC | NASHVILLE, TN | 9,268,949 | $62.07M |
| 84 | KAISER FOUNDATION HEALTH PLAN OF THE NORTHWEST | PORTLAND, OR | 1,337,993 | $61.71M |
| 85 | LATARA ENTERPRISE INC. | POMONA, CA | 9,299,969 | $61.65M |
| 86 | MEMPHIS PATHOLOGY LABORATORY | MEMPHIS, TN | 7,389,083 | $61.43M |
| 87 | CLINICAL ASSOCIATES, LLC | LOUISVILLE, KY | 2,700,271 | $60.75M |
| 88 | ACUTIS DIAGNOSTICS INC | HICKSVILLE, NY | 3,035,746 | $60.64M |
| 89 | REGIONAL TOXICOLOGY SERVICES, LLC | TACOMA, WA | 2,167,827 | $60.35M |
| 90 | LABORATORY CORPORATION OF AMERICA | BURLINGTON, NC | 15,294,807 | $59.75M |
| 91 | QUEST DIAGNOSTICS INCORPORATED | LAS VEGAS, NV | 13,415,550 | $59.32M |
| 92 | NSTX, INC | AUSTIN, TX | 629,175 | $58.21M |
| 93 | LIFESCAN LABS OF ILLINOIS, LLC | SKOKIE, IL | 2,207,151 | $57.98M |
| 94 | ESOTERIX GENETIC LABORATORIES, LLC | WESTBOROUGH, MA | 764,966 | $56.93M |
| 95 | TRUETOX LABORATORIES LLC | GARDEN CITY PARK, NY | 1,598,530 | $56.43M |
| 96 | JOINT VENTURE HOSPITAL LABORATORIES | ALLEN PARK, MI | 4,794,967 | $56.38M |
| 97 | SLOCUM DICKSON MEDICAL GROUP PLLC | NEW HARTFORD, NY | 1,398,165 | $54.06M |
| 98 | UVA CULPEPER MEDICAL CENTER | CULPEPER, VA | 1,045,825 | $53.94M |
| 99 | LABORATORY CORPORATION OF AMERICA HOLDINGS | RESEARCH TRIANGLE PARK, NC | 555,582 | $53.17M |
| 100 | CARIS MPI, INC. | PHOENIX, AZ | 669,883 | $51.66M |